+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2025

  • ID: 5213898
  • Report
  • December 2020
  • Region: Global
  • 185 Pages
  • Markets and Markets
The Global Drug Screening Market is Projected to Reach USD 10.0 Billion by 2025, from USD 4.5 Billion in 2020

FEATURED COMPANIES

  • Alere (US)
  • Drägerwerk (Germany)
  • Lifeloc (US)
  • Omega Laboratories (US)
  • Premier Biotech (US)
  • Quest Diagnostics (US)

The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period. Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches. The emerging countries are also expected to offer strong growth opportunities for players in the market. On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growth.



Drug screening services are expected to grow at the highest CAGR during the forecast period

Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.

By sample type, urine samples are expected to dominate the market during the forecast period

The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

North America will dominate the market during the forecast period

Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the drug screening market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 57%, Tier 2: 30%, and Tier 3: 13%
  • By Designation - C-level: 25%, D-level: 44%, and Others: 33%
  • By Region - North America: 40%, Europe: 29%, Asia Pacific: 19%, and Rest of the World: 12%

List of Companies Profiled in the Report

  • LabCorp (US)
  • Alere (US)
  • Thermo Fisher (US)
  • Drägerwerk (Germany)
  • Quest Diagnostics (US)
  • Alfa Scientific Designs (US)
  • Lifeloc (US)
  • MPD, Inc. (US)
  • OraSure (US)
  • Omega Laboratories (US)
  • Premier Biotech (US)
  • Psychemedics (US)
  • Roche (Switzerland)
  • Shimadzu (Japan)
  • Seimens Healthineers (US)
  • American Bio Medica Corporation (US)
  • Sciteck, Inc. (US)
  • ACM Global Laboratories (US)
  • CareHealth America (US)
  • Clinical Reference Laboratory (US)

Research Coverage:

This report provides a detailed picture of the global drug screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on drug screening offered by the top 20 players in the drug screening market. The report analyses the drug screening market by product and service, sample type, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alere (US)
  • Drägerwerk (Germany)
  • Lifeloc (US)
  • Omega Laboratories (US)
  • Premier Biotech (US)
  • Quest Diagnostics (US)

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders
1.7 Summary of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.2 Secondary Data
2.2.1 Key Data from Secondary Sources
2.3 Primary Data
2.3.1 Primary Sources
2.3.2 Breakdown of Primary Interviews
Figure 2 Breakdown of Primary Interviews: by Company, Designation, and Region
Figure 3 Breakdown of Primary Interviews (Demand Side): by End-user and Region
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach: Contribution-Based Market Size Estimation
Figure 4 Drug Screening Market: Top-Down Approach
2.4.3 Growth Forecast
2.5 Market Breakdown & Data Triangulation
Figure 5 Data Triangulation Methodology
2.6 Assumptions for the Study

3 Executive Summary
Figure 6 Drug Screening Services Market to Record Highest CAGR During 2020-2025
Figure 7 Analytical Instruments Segment to Lead the Drug Screening Products Market, 2020-2025 (USD Billion)
Figure 8 Workplaces to Show the Highest Growth in the End-User Market, 2020-2025 (USD Billion)
Figure 9 Geographic Snapshot of the Drug Screening Market

4 Premium Insights
4.1 Attractive Opportunities in the Drug Screening Market
Figure 10 Growing Consumption of Drugs and Alcohol to Drive Market Growth
4.2 Drug Screening Market, by Product & Service
Figure 11 Services Segment to Register Highest CAGR During 2020-2025 (USD Billion)
4.3 Drug Screening Market, by Sample Type
Figure 12 Oral Fluid Samples Segment to Witness Highest CAGR, 2020-2025 (USD Billion)
4.4 Drug Screening Market: Geographic Snapshot
Figure 13 India to Witness Highest CAGR During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 14 Drug Screening Market: Drivers, Restraints, Opportunities, and Challenges
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growing Drug and Alcohol Consumption
5.3.1.2 Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
5.3.1.3 Regulatory Approvals and Product & Service Launches
Table 1 Key Product & Service Launches (2014-2017)
Table 2 Recent Approvals for Drug and Alcohol Testing Products and Services
5.3.2 Restraints
5.3.2.1 Ban on Alcohol Consumption in Several Islamic Countries
5.3.2.2 Prohibition on Workplace Drug Testing in Some Countries
5.3.3 Opportunities
5.3.3.1 Oral Fluid Testing
5.3.3.2 Fingerprint-Based Drug Screening
5.3.3.3 Emerging Economies
5.3.4 Challenges
5.3.4.1 Accuracy and Specificity Concerns Related to Breathalyzers
5.4 Value Chain Analysis
Figure 15 Major Value is Added During the Manufacturing and Assembly Phases
5.5 Ecosystem Analysis of the Drug Screening Products Market
Figure 16 Ecosystem Analysis
5.6 COVID-19 Impact on the Drug Screening Market

6 Drug Screening Market, by Product & Service
6.1 Introduction
Table 3 Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
6.2 Drug Screening Services
6.2.1 Growing Drug Consumption and Stringent Laws Have Ensured Demand Spike for Services
Table 4 Drug Screening Services Market, by Region, 2018-2025 (USD Million)
6.3 Drug Screening Products
Table 5 Drug Screening Products Market, by Type, 2018-2025 (USD Million)
6.3.1 Analytical Instruments
Table 6 Drug Screening Products Market for Analytical Instruments,By Type, 2018-2025 (USD Million)
Table 7 Drug Screening Products Market for Analytical Instruments, by Region, 2018-2025 (USD Million)
6.3.1.1 Breathalyzers
6.3.1.1.1 Law Enforcement Agencies Widely Use Breathalyzers
Table 8 Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 9 Breathalyzers Market, by Region, 2018-2025 (USD Million)
6.3.1.1.2 Fuel-Cell Breathalyzers
Table 10 Fuel-Cell Breathalyzers Market, by Region,2018-2025 (USD Million)
6.3.1.1.3 Semiconductor Breathalyzers
Table 11 Semiconductor Breathalyzers Market, by Region, 2018-2025 (USD Million)
6.3.1.1.4 Other Breathalyzers
Table 12 Other Breathalyzers Market, by Region, 2018-2025 (USD Million)
6.3.1.2 Immunoassay Analyzers
6.3.1.2.1 North America is the Largest Market for Immunoassay Analyzers
Table 13 Immunoassay Analyzers Market, by Region, 2018-2025 (USD Million)
6.3.1.3 Chromatography Instruments
6.3.1.3.1 Chromatography Shows Higher Accuracy Than Immunoassays
Table 14 Chromatography Instruments Market, by Region, 2018-2025 (USD Million)
6.3.2 Rapid Testing Devices
Table 15 Drug Screening Products Market for Rapid Testing Devices, by Type, 2018-2025 (USD Million)
Table 16 Drug Screening Products Market for Rapid Testing Devices, by Region, 2018-2025 (USD Million)
6.3.2.1 Urine Testing Devices
6.3.2.1.1 Urine Testing Provides Results Within Minutes and is Used in a Wide Range of Applications
Table 17 Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 18 Urine Testing Devices Market, by Region, 2018-2025 (USD Million)
6.3.2.1.2 Drug Testing Cups
Table 19 Drug Testing Cups Market, by Region, 2018-2025 (USD Million)
6.3.2.1.3 Dip Cards
Table 20 Dip Cards Market, by Region, 2018-2025 (USD Million)
6.3.2.1.4 Drug Testing Cassettes
Table 21 Drug Testing Cassettes Market, by Region, 2018-2025 (USD Million)
6.3.2.2 Oral Fluid Testing Devices
6.3.2.2.1 Short Detection Windows, Noninvasive Nature, and Low Chance of Sample Tampering Have Ensured Interest in Oral Fluid Testing
Table 22 Oral Fluid Testing Devices Market, by Region, 2018-2025 (USD Million)
6.3.3 Consumables
Table 23 Drug Screening Consumables Market, by Type, 2018-2025 (USD Million)
Table 24 Drug Screening Consumables Market, by Region, 2018-2025 (USD Million)
6.3.3.1 Assay Kits
6.3.3.1.1 Immunoassay Kits Provide a Rapid, Inexpensive Method to Screen Samples
Table 25 Assay Kits Market, by Region, 2018-2025 (USD Million)
6.3.3.2 Sample Collection Devices
6.3.3.2.1 APAC Market for Sample Collection Devices to See High Growth
Table 26 Sample Collection Devices Market, by Region, 2018-2025 (USD Million)
6.3.3.3 Calibrators & Controls
6.3.3.3.1 Thermo Fisher Scientific is a Prominent Manufacturer of Calibrators & Controls
Table 27 Calibrators & Controls Market, by Region, 2018-2025 (USD Million)
6.3.3.4 Other Consumables
Table 28 Other Consumables Market, by Region, 2018-2025 (USD Million)

7 Drug Screening Market, by Sample Type
7.1 Introduction
Table 29 Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
7.2 Urine Samples
7.2.1 Ease of Collection and Well-Developed Technology Have Supported the Use of Urine Samples
Table 30 Drug Screening Market for Urine Samples, by Region, 2018-2025 (USD Million)
7.3 Breath Samples
7.3.1 Breath Alcohol Tests See Wide Usage in Workplace Testing and Law Enforcement Applications
Table 31 Drug Screening Market for Breath Samples, by Region, 2018-2025 (USD Million)
7.4 Oral Fluid Samples
7.4.1 Noninvasive Sample Collection and Low Chance of Adulteration Have Supported Reliance on Oral Samples
Table 32 Drug Screening Market for Oral Fluid Samples, by Region, 2018-2025 (USD Million)
7.5 Hair Samples
7.5.1 Hair Samples Can Provide Insights into Long-Term Drug Use
Table 33 Drug Screening Market for Hair Samples, by Region, 2018-2025 (USD Million)
7.6 Other Samples
Table 34 Drug Screening Market for Other Samples, by Region, 2018-2025 (USD Million)

8 Drug Screening Market, by End-user
8.1 Introduction
Table 35 Drug Screening Market, by End-user, 2018-2025 (USD Million)
8.2 Workplaces
8.2.1 Workplaces to Show the Highest Growth of All End-User Segments
Table 36 Drug Screening Market for Workplaces, by Region, 2018-2025 (USD Million)
8.3 Drug Testing Laboratories
8.3.1 Rising Number of Drug Abuse Cases and Development of Specialized Assays and Tests Support Market Growth
Table 37 Drug Screening Market for Drug Testing Laboratories, by Region, 2018-2025 (USD Million)
8.4 Criminal Justice Systems & Law Enforcement Agencies
8.4.1 Urine is the Most Commonly Used Sample in Criminal Justice Systems
Table 38 Drug Screening Market for Criminal Justice Systems & Law Enforcement Agencies, by Region, 2018-2025 (USD Million)
8.5 Hospitals
8.5.1 Rising Drug Abuse Incidence Has Resulted in An Increase in Emergency Department Visits
Table 39 Drug Screening Market for Hospitals, by Region, 2018-2025 (USD Million)
8.6 Drug Treatment Centers
8.6.1 Availability of Government Support is a Key Growth Driver
Table 40 Drug Screening Market for Drug Treatment Centers, by Region, 2018-2025 (USD Million)
8.7 Individual Users
8.7.1 Personal Breathalyzers Have Seen Growing Adoption
Table 41 Drug Screening Market for Individual Users, by Region, 2018-2025 (USD Million)
8.8 Pain Management Centers
8.8.1 Rising Substance Abuse Has Supported Drug Testing Activity in Pain Management Applications
Table 42 Drug Screening Market for Pain Management Centers, by Region, 2018-2025 (USD Million)
8.9 Schools & Colleges
8.9.1 while Some Countries Support Drug Tests in Schools & Colleges, Others Are Opposed or Have Banned Testing
Table 43 Drug Screening Market for Schools & Colleges, by Region, 2018-2025 (USD Million)

9 Drug Screening Market, by Region
9.1 Introduction
Table 44 Drug Screening Market, by Region, 2018-2025 (USD Million)
9.2 North America
Figure 17 North America: Drug Screening Market Snapshot
Table 45 North America: Drug Screening Market, by Country, 2018-2025 (USD Million)
Table 46 North America: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 47 North America: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 48 North America: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 49 North America: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 50 North America: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 51 North America: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 52 North America: Consumables Market, by Type, 2018-2025 (USD Million)
Table 53 North America: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 54 North America: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.2.1 US
9.2.1.1 the US Holds the Largest Share of the Market in North America
Table 55 Us: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 56 Us: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 57 Us: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 58 Us: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 59 Us: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 60 Us: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 61 Us: Consumables Market, by Type, 2018-2025 (USD Million)
Table 62 Us: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 63 Us: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.2.2 Canada
9.2.2.1 Canada Has No Legislation Governing Drug and Alcohol Testing in the Workplace
Table 64 Canada: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 65 Canada: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 66 Canada: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 67 Canada: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 68 Canada: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 69 Canada: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 70 Canada: Consumables Market, by Type, 2018-2025 (USD Million)
Table 71 Canada: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 72 Canada: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.3 Europe
Table 73 Europe: Drug Screening Market, by Country, 2018-2025 (USD Million)
Table 74 Europe: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 75 Europe: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 76 Europe: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 77 Europe: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 78 Europe: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 79 Europe: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 80 Europe: Consumables Market, by Type, 2018-2025 (USD Million)
Table 81 Europe: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 82 Europe: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.3.1 Germany
9.3.1.1 Germany is the Largest Market for Drug Screening Products & Services in Europe
Table 83 Germany: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 84 Germany: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 85 Germany: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 86 Germany: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 87 Germany: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 88 Germany: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 89 Germany: Consumables Market, by Type, 2018-2025 (USD Million)
Table 90 Germany: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 91 Germany: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.3.2 France
9.3.2.1 Cannabis and Cocaine Are the Most Widely Used Illicit Substances in France
Table 92 France: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 93 France: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 94 France: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 95 France: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 96 France: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 97 France: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 98 France: Consumables Market, by Type, 2018-2025 (USD Million)
Table 99 France: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 100 France: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.3.3 UK
9.3.3.1 Favorable Government Support is a Prominent Driver of Market Growth in the UK
Table 101 Uk: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 102 Uk: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 103 Uk: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 104 Uk: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 105 Uk: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 106 Uk: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 107 Uk: Consumables Market, by Type, 2018-2025 (USD Million)
Table 108 Uk: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 109 Uk: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.3.4 RoE
Table 110 RoE: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 111 RoE: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 112 RoE: Analytical Instruments Market, by Type,2018-2025 (USD Million)
Table 113 RoE: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 114 RoE: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 115 RoE: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 116 RoE: Consumables Market, by Type, 2018-2025 (USD Million)
Table 117 RoE: Drug Screening Market, by Sample Type,2018-2025 (USD Million)
Table 118 RoE: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.4 APAC
Figure 18 APAC: Drug Screening Market Snapshot
Table 119 APAC: Drug Screening Market, by Country, 2018-2025 (USD Million)
Table 120 APAC: Drug Screening Market, by Product & Service,2018-2025 (USD Million)
Table 121 APAC: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 122 APAC: Analytical Instruments Market, by Type,2018-2025 (USD Million)
Table 123 APAC: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 124 APAC: Rapid Testing Devices Market, by Type,2018-2025 (USD Million)
Table 125 APAC: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 126 APAC: Consumables Market, by Type, 2018-2025 (USD Million)
Table 127 APAC: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 128 APAC: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.4.1 China
9.4.1.1 China Holds the Largest Share of the APAC Market
Table 129 China: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 130 China: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 131 China: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 132 China: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 133 China: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 134 China: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 135 China: Consumables Market, by Type, 2018-2025 (USD Million)
Table 136 China: Drug Screening Market, by Sample Type,2018-2025 (USD Million)
Table 137 China: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.4.2 Japan
9.4.2.1 Stringent Laws and Growing Awareness Are Key Market Drivers in Japan
Table 138 Japan: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 139 Japan: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 140 Japan: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 141 Japan: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 142 Japan: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 143 Japan: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 144 Japan: Consumables Market, by Type, 2018-2025 (USD Million)
Table 145 Japan: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 146 Japan: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.4.3 India
9.4.3.1 India is Among the Fastest-Growing Segments of the Drug Screening Market
Table 147 India: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 148 India: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 149 India: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 150 India: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 151 India: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 152 India: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 153 India: Consumables Market, by Type, 2018-2025 (USD Million)
Table 154 India: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 155 India: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.4.4 Roapac
Table 156 Roapac: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 157 Roapac: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 158 Roapac: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 159 Roapac: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 160 Roapac: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 161 Roapac: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 162 Roapac: Consumables Market, by Type, 2018-2025 (USD Million)
Table 163 Roapac: Drug Screening Market, by Sample Type,2018-2025 (USD Million)
Table 164 Roapac: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.5 RoW
Table 165 Row: Drug Screening Market, by Region, 2018-2025 (USD Million)
Table 166 Row: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 167 Row: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 168 Row: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 169 Row: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 170 Row: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 171 Row: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 172 Row: Consumables Market, by Type, 2018-2025 (USD Million)
Table 173 Row: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 174 Row: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.5.1 Latam
9.5.1.1 Increasing Incidence of Drug Overdose and Favorable Government Support Are Key Growth Drivers in Latam
Table 175 Latam: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 176 Latam: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 177 Latam: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 178 Latam: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 179 Latam: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 180 Latam: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 181 Latam: Consumables Market, by Type, 2018-2025 (USD Million)
Table 182 Latam: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 183 Latam: Drug Screening Market, by End-user, 2018-2025 (USD Million)
9.5.2 Middle East & Africa
9.5.2.1 Rising Drug Abuse and Growing Emphasis on Testing Support Market Growth in the Mea
Table 184 Mea: Drug Screening Market, by Product & Service, 2018-2025 (USD Million)
Table 185 Mea: Drug Screening Products Market, by Type, 2018-2025 (USD Million)
Table 186 Mea: Analytical Instruments Market, by Type, 2018-2025 (USD Million)
Table 187 Mea: Breathalyzers Market, by Type, 2018-2025 (USD Million)
Table 188 Mea: Rapid Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 189 Mea: Urine Testing Devices Market, by Type, 2018-2025 (USD Million)
Table 190 Mea: Consumables Market, by Type, 2018-2025 (USD Million)
Table 191 Mea: Drug Screening Market, by Sample Type, 2018-2025 (USD Million)
Table 192 Mea: Drug Screening Market, by End-user, 2018-2025 (USD Million)

10 Competitive Landscape
10.1 Overview
Figure 19 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2017 and 2020
Figure 20 Market Evolution Framework
10.2 Competitive Situations and Trends
10.2.1 Partnerships, Agreements, and Collaborations (2017-2020)
10.2.2 Product Launches (2017-2020)
10.2.3 Approvals (2017-2020)
10.2.4 Expansions (2017-2020)
10.2.5 Acquisitions (2017-2020)

11 Company Evaluation Matrix and Company Profiles
11.1 Company Evaluation Matrix Definitions and Methodology
11.1.1 Market Player Ranking, 2019
Figure 21 Drug Screening Services Market Ranking, by Key Player, 2019
Figure 22 Rapid Testing Devices Market Ranking, by Key Player, 2019
11.2 Company Evaluation Matrix
11.2.1 Stars
11.2.2 Emerging Leaders
11.2.3 Pervasive Players
11.2.4 Participants
Figure 23 Vendor Dive Comparison Matrix: Drug Screening Market
11.3 Competitive Leadership Mapping (Start-Ups)
11.3.1 Progressive Companies
11.3.2 Starting Blocks
11.3.3 Responsive Companies
11.3.4 Dynamic Companies
Figure 24 Vendor Dive Comparison Matrix for Start-Ups: Drug Screening Market
11.4 Company Profiles
(Business Overview, Products Offered, Recent Developments, Analyst's View)*
11.4.1 Labcorp
Figure 25 Labcorp: Company Snapshot (2019)
11.4.2 Quest Diagnostics
Figure 26 Quest Diagnostics: Company Snapshot (2019)
11.4.3 Alere
Figure 27 Abbott Laboratories: Company Snapshot (2019)
11.4.4 Orasure
Figure 28 Orasure: Company Snapshots (2019)
11.4.5 Alfa Scientific Designs
11.4.6 Thermo Fisher Scientific
Figure 29 Thermo Fisher Scientific: Company Snapshot (2019)
11.4.7 Drägerwerk
Figure 30 Drägerwerk: Company Snapshot (2019)
11.4.8 Lifeloc
Figure 31 Lifeloc: Company Snapshot (2019)
11.4.9 Mpd Inc.
11.4.10 Omega Laboratories
11.4.11 Premier Biotech
11.4.12 Psychemedics
Figure 32 Psychemedics: Company Snapshot (2019)
11.4.13 Roche
Figure 33 Roche: Company Snapshot (2019)
11.4.14 Shimadzu
Figure 34 Shimadzu: Company Snapshot (2019)
11.4.15 Siemens Healthineers
Figure 35 Siemens Healthineers: Company Snapshot (2019)
11.4.16 American Bio Medica Corporation
11.4.17 Sciteck, Inc.
11.4.18 Acm Global Laboratories
11.4.19 Carehealth America
11.4.20 Clinical Reference Laboratory
*Business Overview, Products Offered, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

Note: Product cover images may vary from those shown

Loading
LOADING...

  • ACM Global Laboratories (US)
  • Alere (US)
  • Alfa Scientific Designs (US)
  • American Bio Medica Corporation (US)
  • CareHealth America (US)
  • Clinical Reference Laboratory (US)
  • Drägerwerk (Germany)
  • LabCorp (US)
  • Lifeloc (US)
  • MPD, Inc. (US)
  • Omega Laboratories (US)
  • OraSure (US)
  • Premier Biotech (US)
  • Psychemedics (US)
  • Quest Diagnostics (US)
  • Roche (Switzerland)
  • Sciteck, Inc. (US)
  • Seimens Healthineers (US)
  • Shimadzu (Japan)
  • Thermo Fisher (US)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll